BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 32124097)

  • 1. Update on Pediatric Optic Neuritis.
    Gise RA; Heidary G
    Curr Neurol Neurosci Rep; 2020 Mar; 20(3):4. PubMed ID: 32124097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic neuritis in Turkish children and adolescents: A multicenter retrospective study.
    Direk MÇ; Besen Ş; Öncel İ; Günbey C; Özdoğan O; Orgun LT; Sahin S; Cansu A; Yıldız N; Kanmaz S; Yılmaz S; Tekgül H; Türkdoğan D; Ünver O; Thomas GÖ; Başıbüyük S; Yılmaz D; Kurt AN; Gültutan P; Özsoy Ö; Yiş U; Kurul SH; Güngör S; Özgör B; Karadağ M; Dündar NO; Gençpınar P; Bildik O; Orak SA; Kabur ÇÇ; Kara B; Karaca Ö; Canpolat M; Gümüş H; Per H; Yılmaz Ü; Karaoğlu P; Ersoy Ö; Tosun A; Öztürk SB; Yüksel D; Atasoy E; Gücüyener K; Yıldırım M; Bektaş Ö; Çavuşoğlu D; Yarar Ç; Güngör O; Mert GG; Sarıgeçili E; Edizer S; Çetin İD; Aydın S; Diler B; Özdemir AA; Erol İ; Okuyaz Ç; Anlar B
    Mult Scler Relat Disord; 2024 Jan; 81():105149. PubMed ID: 38096730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on pediatric optic neuritis.
    Lock JH; Newman NJ; Biousse V; Peragallo JH
    Curr Opin Ophthalmol; 2019 Nov; 30(6):418-425. PubMed ID: 31433309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optic neuropathy in positive anti-MOG antibody syndrome].
    Merabtene L; Vignal Clermont C; Deschamps R
    J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis.
    Caron-Cantin M; Cestari DM; Fortin E
    Curr Opin Ophthalmol; 2019 Nov; 30(6):412-417. PubMed ID: 31503075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
    Kaushik M; Burdon MA
    J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis in the era of biomarkers.
    Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT
    Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ; Bhatti MT
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Typical and atypical optic neuritis].
    Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
    Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
    Gospe SM; Chen JJ; Bhatti MT
    Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
    Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
    Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT].
    Almer Z
    Harefuah; 2022 Oct; 161(10):645-651. PubMed ID: 36315205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis.
    Saitakis G; Chwalisz BK
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on glial antibody-mediated optic neuritis.
    Song H; Zhou H; Wei S
    Jpn J Ophthalmol; 2022 Sep; 66(5):405-412. PubMed ID: 35895155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on optic neuritis.
    Kraker JA; Chen JJ
    J Neurol; 2023 Oct; 270(10):5113-5126. PubMed ID: 37542657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Treatment of Acute Optic Neuritis.
    Keyhanian K; Chwalisz BK
    Semin Ophthalmol; 2023 Aug; 38(6):511-514. PubMed ID: 37162276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.
    Tajfirouz DA; Bhatti MT; Chen JJ
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.